Merck completes $10 billion acquisition of Verona Pharma
PositiveFinancial Markets

Merck has successfully completed its $10 billion acquisition of Verona Pharma, a move that strengthens its position in the pharmaceutical industry. This acquisition is significant as it allows Merck to expand its portfolio and enhance its research capabilities, particularly in respiratory diseases. The deal reflects Merck's commitment to innovation and growth, which could lead to new treatments and improved patient outcomes.
— Curated by the World Pulse Now AI Editorial System